Schedule 13D ownership disclosure
Checkmate Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 162818108
Event date: 2021-11-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-315374
- Form type
- SC 13D
- Filer
- Checkmate Pharmaceuticals, Inc.
- CIK
- CIK 1651431
- Filed
- Nov 01, 2021
- Reporting period
- Nov 01, 2021
- Description
- Schedule 13D beneficial ownership